These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 11585771

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
    Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S.
    Prostate; 2005 Dec 01; 65(4):287-98. PubMed ID: 16015608
    [Abstract] [Full Text] [Related]

  • 4. Androgen-repressed phenotype in human prostate cancer.
    Zhau HY, Chang SM, Chen BQ, Wang Y, Zhang H, Kao C, Sang QA, Pathak SJ, Chung LW.
    Proc Natl Acad Sci U S A; 1996 Dec 24; 93(26):15152-7. PubMed ID: 8986779
    [Abstract] [Full Text] [Related]

  • 5. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ, Robson CN, Neal DE, Leung HY.
    Oncogene; 2002 Aug 01; 21(33):5069-80. PubMed ID: 12140757
    [Abstract] [Full Text] [Related]

  • 6. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
    Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, Luo J, De Marzo AM, Isaacs WB.
    Cancer Res; 2003 Nov 01; 63(21):7365-76. PubMed ID: 14612535
    [Abstract] [Full Text] [Related]

  • 7. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB.
    Cancer Res; 1995 Jul 15; 55(14):3197-203. PubMed ID: 7606741
    [Abstract] [Full Text] [Related]

  • 8. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
    Xu LL, Srikantan V, Sesterhenn IA, Augustus M, Dean R, Moul JW, Carter KC, Srivastava S.
    J Urol; 2000 Mar 15; 163(3):972-9. PubMed ID: 10688034
    [Abstract] [Full Text] [Related]

  • 9. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.
    Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538
    [Abstract] [Full Text] [Related]

  • 10. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z, Stober J, Gast A, Peterziel H, Hobisch A, Radmayr C, Hittmair A, Bartsch G, Cato AC, Klocker H.
    Cancer Detect Prev; 1996 Mar 01; 20(1):68-75. PubMed ID: 8907206
    [Abstract] [Full Text] [Related]

  • 11. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD, Lambert JR, Nordeen SK.
    Mol Cancer Res; 2010 Dec 01; 8(12):1643-55. PubMed ID: 21047772
    [Abstract] [Full Text] [Related]

  • 12. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
    Gregory CW, Johnson RT, Mohler JL, French FS, Wilson EM.
    Cancer Res; 2001 Apr 01; 61(7):2892-8. PubMed ID: 11306464
    [Abstract] [Full Text] [Related]

  • 13. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.
    Attardi BJ, Burgenson J, Hild SA, Reel JR.
    Mol Cell Endocrinol; 2004 Jul 30; 222(1-2):121-32. PubMed ID: 15249132
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line.
    Joly-Pharaboz MO, Ruffion A, Roch A, Michel-Calemard L, André J, Chantepie J, Nicolas B, Panaye G.
    J Steroid Biochem Mol Biol; 2000 Jul 30; 73(5):237-49. PubMed ID: 11070352
    [Abstract] [Full Text] [Related]

  • 15. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.
    Lu S, Tsai SY, Tsai MJ.
    Cancer Res; 1997 Oct 15; 57(20):4511-6. PubMed ID: 9377562
    [Abstract] [Full Text] [Related]

  • 16. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H.
    Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959
    [Abstract] [Full Text] [Related]

  • 17. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
    Dai JL, Burnstein KL.
    Mol Endocrinol; 1996 Dec 15; 10(12):1582-94. PubMed ID: 8961268
    [Abstract] [Full Text] [Related]

  • 18. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T, Nakamura K, Araki H, Kusaka M, Yamaoka M.
    Cancer Res; 2003 Sep 01; 63(17):5622-8. PubMed ID: 14500404
    [Abstract] [Full Text] [Related]

  • 19. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J, Arnold JT, Isaacs JT.
    Cancer Res; 2001 Jul 01; 61(13):5038-44. PubMed ID: 11431338
    [Abstract] [Full Text] [Related]

  • 20. Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.
    Marques RB, Erkens-Schulze S, de Ridder CM, Hermans KG, Waltering K, Visakorpi T, Trapman J, Romijn JC, van Weerden WM, Jenster G.
    Int J Cancer; 2005 Nov 01; 117(2):221-9. PubMed ID: 15900601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.